retatrutide vs tirzepatide side effects vs. Tirzepatide: The New Contender vs. the Current Leader Retatrutide vs Tirzepatide Key Differences|

Supports Wound Healing: Accelerates skin recovery from micro-needling, laser, or other cosmetic procedures

On April 1, 2026, the FDA approved orforglipron (Foundayo) by Eli Lilly for adults with obesity or overweight who also have weight-related medical problems to reduce excess body weight and maintain weight reduction long term, alongside a reduced-calorie diet and increased physical activity

This can improve tissue health and possibly slow down aging

Choosing the right treatment for type 2 diabetes and obesity is crucial, and understanding the nuances between medications like Mazdutide and Tirzepatide is just the beginning